5AM-1MQ Selectively inhibits the Nicotinamide N-methyltransferase (NNMT) enzyme to increase cellular NAD+ levels and metabolic expenditure
Cancer Res (2019) 79(23):59209
Purpose Peptides emphasizes transparency, consistency, and reproducibility to support dependable research outcomes
5-Amino-1MQ for Muscle Repair Since 5-amino-1MQ inhibits NNMT in skeletal muscle and enhances the activity of GLUT4, the molecule may represent a promising intervention to improve workout capacity and physical performance

Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018

Clinical studies show that B12 injections have no major side effects, though rare cases of sensitivity may occur [20]